• How many people get 'long COVID'? More t

    From ScienceDaily@1:317/3 to All on Wed Oct 13 21:30:40 2021
    How many people get 'long COVID'? More than half, researchers find
    Half of COVID survivors experience lingering symptoms six months after recovery

    Date:
    October 13, 2021
    Source:
    Penn State
    Summary:
    More than half of the 236 million people who have been diagnosed
    with COVID-19 worldwide since December 2019 will experience
    post-COVID symptoms -- more commonly known as 'long COVID' --
    up to six months after recovering, according to researchers. The
    research team said that governments, health care organizations and
    public health professionals should prepare for the large number of
    COVID-19 survivors who will need care for a variety of psychological
    and physical symptoms.



    FULL STORY ==========================================================================
    More than half of the 236 million people who have been diagnosed
    with COVID-19 worldwide since December 2019 will experience post-COVID
    symptoms -- more commonly known as "long COVID" -- up to six months after recovering, according to Penn State College of Medicine researchers. The research team said that governments, health care organizations and
    public health professionals should prepare for the large number of
    COVID-19 survivors who will need care for a variety of psychological
    and physical symptoms.


    ========================================================================== During their illnesses, many patients with COVID-19 experience symptoms,
    such as tiredness, difficulty breathing, chest pain, sore joints and
    loss of taste or smell.

    Until recently, few studies have evaluated patients' health after
    recovering from the coronavirus. To better understand the short-
    and long-term health effects of the virus, the researchers examined
    worldwide studies involving unvaccinated patients who recovered from
    COVID-19. According to the findings, adults, as well as children, can experience several adverse health issues for six months or longer after recovering from COVID-19.

    The researchers conducted a systematic review of 57 reports that included
    data from 250,351 unvaccinated adults and children who were diagnosed
    with COVID-19 from December 2019 through March 2021. Among those studied,
    79% were hospitalized, and most patients (79%) lived in high-income
    countries. Patients' median age was 54, and the majority of individuals
    (56%) were male.

    The researchers analyzed patients' health post-COVID during
    three intervals at one month (short-term), two to five months (intermediate-term) and six or more months (long-term).

    According to the findings, survivors experienced an array of residual
    health issues associated with COVID-19. Generally, these complications
    affected a patient's general well-being, their mobility or organ
    systems. Overall, one in two survivors experienced long-term COVID manifestations. The rates remained largely constant from one month
    through six or more months after their initial illness.



    ==========================================================================
    The investigators noted several trends among survivors, such as:
    * General well-being:More than half of all patients reported weight
    loss,
    fatigue, fever or pain.

    * Mobility:Roughly one in five survivors experienced a decrease in
    mobility.

    * Neurologic concerns: Nearly one in four survivors experienced
    difficulty
    concentrating.

    * Mental health disorders: Nearly one in three patients were
    diagnosed with
    generalized anxiety disorders.

    * Lung abnormalities: Six in ten survivors had chest imaging
    abnormality
    and more than a quarter of patients had difficulty breathing.

    * Cardiovascular issues: Chest pain and palpitations were among the
    commonly reported conditions.

    * Skin conditions:Nearly one in five patients experienced hair loss or
    rashes.

    * Digestive issues: Stomach pain, lack of appetite, diarrhea and
    vomiting
    were among the commonly reported conditions.

    "These findings confirm what many health care workers and COVID-19
    survivors have been claiming, namely, that adverse health effects from
    COVID-19 can linger," said co-lead investigator Vernon Chinchilli, chair
    of the Department of Public Health Sciences. "Although previous studies
    have examined the prevalence of long COVID symptoms among patients, this
    study examined a larger population, including people in high-, middle-
    and low-income countries, and examined many more symptoms. Therefore,
    we believe our findings are quite robust given the available data."
    "The burden of poor health in COVID-19 survivors is overwhelming," said
    co-lead investigator Dr. Paddy Ssentongo, assistant professor at the
    Penn State Center for Neural Engineering. "Among these are the mental
    health disorders. One's battle with COVID doesn't end with recovery from
    the acute infection.

    Vaccination is our best ally to prevent getting sick from COVID-19 and to reduce the chance of long-COVID even in the presence of a breakthrough infection." The mechanisms by which COVID-19 causes lingering symptoms
    in survivors are not fully understood. These symptoms could result from immune-system overdrive triggered by the virus, lingering infection, reinfection or an increased production of autoantibodies (antibodies
    directed at their own tissues). The SARS-CoV-2 virus, the agent that
    causes COVID-19, can access, enter and live in the nervous system. As
    a result, nervous system symptoms such as taste or smell disorders,
    memory impairment and decreased attention and concentration commonly
    occur in survivors.

    "Our study was not designed to confirm COVID-19 as the sole cause of these symptoms. It is plausible that symptoms reported by patients in some of
    the studies examined were due to some other causes," said Ssentongo.



    ========================================================================== According to the researchers, early intervention will be critical for
    improving the quality of life for many COVID-19 survivors. They said that
    in the years ahead, health care providers will likely see an influx of
    patients with psychiatric and cognitive problems, such as depression,
    anxiety or post- traumatic stress disorder, who were otherwise healthy
    before their COVID-19 infection. Based on these findings, health care
    providers should plan and allocate resources accordingly in order to effectively monitor and treat these conditions.

    The research team noted that these long-term health conditions may cause increased demand for medical care and could overwhelm health care systems, particularly in low- and middle-income countries. They said the findings
    from this study could help shape treatment plans to improve care for
    COVID-19 patients and establish integrated evidence-based clinical
    management for those affected.

    "Since survivors may not have the energy or resources to go back and
    forth to their health care providers, one-stop clinics will be critical to effectively and efficiently manage patients with long COVID," Ssentongo
    said. "Such clinics could reduce medical costs and optimize access to
    care, especially in populations with historically larger health care disparities." Destin Groff, Ashley Sun, Anna Ssentongo, Djibril Ba,
    Dr. Alain Lekoubou; Dr.

    John Oh; and Dr. Jessica Ericson from Penn State College of Medicine contributed to this research. Nicholas Parsons from Deakin University
    and Govinda Poudel from Australian Catholic University in Australia also contributed to this research.

    The researchers declare no conflicts of interest or specific funding
    for this research.

    ========================================================================== Story Source: Materials provided by Penn_State. Original written by
    Tracy Cox. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Destin Groff, Ashley Sun, Anna E. Ssentongo, Djibril M. Ba, Nicholas
    Parsons, Govinda R. Poudel, Alain Lekoubou, John S. Oh, Jessica E.

    Ericson, Paddy Ssentongo, Vernon M. Chinchilli. Short-term and
    Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection:
    A Systematic Review.

    JAMA Network Open, 2021; 4 (10): e2128568 DOI: 10.1001/
    jamanetworkopen.2021.28568 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2021/10/211013114112.htm

    --- up 5 weeks, 6 days, 8 hours, 25 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)